Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from China Traditional Chinese Medicine Holdings Co ( (HK:0570) ) is now available.
China Traditional Chinese Medicine Holdings Co. Limited has announced a delay in sending to shareholders a circular relating to the renewal of certain continuing connected transactions. The circular, which will include details of the transaction agreements, recommendations from the Independent Board Committee, and advice from the Independent Financial Adviser, was originally expected to be dispatched around 16 December 2025 but will now be sent on or before 15 January 2026, as the company needs more time to prepare and finalise the required information; the postponement slightly extends the timetable for shareholder review and approval at the forthcoming extraordinary general meeting but does not alter the substance of the proposed transactions.
The most recent analyst rating on (HK:0570) stock is a Sell with a HK$1.60 price target. To see the full list of analyst forecasts on China Traditional Chinese Medicine Holdings Co stock, see the HK:0570 Stock Forecast page.
More about China Traditional Chinese Medicine Holdings Co
China Traditional Chinese Medicine Holdings Co. Limited is a Hong Kong-incorporated company listed on the Stock Exchange of Hong Kong, operating in the traditional Chinese medicine sector. The group is engaged in the manufacture and sale of traditional Chinese medicine products and related healthcare offerings, serving domestic and international markets through its portfolio of herbal preparations and pharmaceutical formulations.
Average Trading Volume: 34,534,609
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$10.73B
See more insights into 0570 stock on TipRanks’ Stock Analysis page.